Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meng-Meng Ning

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Acta Pharmacologica Sinica|August 28, 2012
Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob miceYue-Jing Wang, Su-Ling Huang, Ying Feng, et al.
Acta Pharmacologica Sinica|May 14, 2020
Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2Meng-Meng Ning, Wen-Ji Yang, Wen-Bo Guan, et al.
Journal of Natural Products|February 28, 2006
Bioactive compounds from Peperomia pellucidaSu Xu, Na Li, Meng-Meng Ning, et al.
Acta Pharmacologica Sinica|June 7, 2016
OL3, a novel low-absorbed TGR5 agonist with reduced side effects, lowered blood glucose via dual actions on TGR5 activation and DPP-4 inhibitionShan-Yao Ma, Meng-Meng Ning, Qing-An Zou, et al.
Biochemical and Biophysical Research Communications|September 30, 2015
Yhhu4488, a novel GPR40 agonist, promotes GLP-1 secretion and exerts anti-diabetic effect in rodent modelsDan-yang Guo, De-wen Li, Meng-meng Ning, et al.
Scientific Reports|June 25, 2016
Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effectHua Cao, Zhi-Xiang Chen, Kai Wang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Acta Pharmacologica Sinica|August 28, 2012
Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob miceYue-Jing Wang, Su-Ling Huang, Ying Feng, et al.
Acta Pharmacologica Sinica|May 14, 2020
Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2Meng-Meng Ning, Wen-Ji Yang, Wen-Bo Guan, et al.
Journal of Natural Products|February 28, 2006
Bioactive compounds from Peperomia pellucidaSu Xu, Na Li, Meng-Meng Ning, et al.
Acta Pharmacologica Sinica|June 7, 2016
OL3, a novel low-absorbed TGR5 agonist with reduced side effects, lowered blood glucose via dual actions on TGR5 activation and DPP-4 inhibitionShan-Yao Ma, Meng-Meng Ning, Qing-An Zou, et al.
Biochemical and Biophysical Research Communications|September 30, 2015
Yhhu4488, a novel GPR40 agonist, promotes GLP-1 secretion and exerts anti-diabetic effect in rodent modelsDan-yang Guo, De-wen Li, Meng-meng Ning, et al.
Scientific Reports|June 25, 2016
Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effectHua Cao, Zhi-Xiang Chen, Kai Wang, et al.
Pageof 1